SMS Pharmaceuticals Ltd

NSE: SMSPHARMA · BSE: 532815 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹469.55
Market cap: ₹4,163 Cr
Revenue (annual): ₹886.9 Cr
Net profit (annual): ₹102.0 Cr
P/E (TTM): 40.6×Sector 47.4×
Promoter holding: 68.07%+0.00% QoQ
FII holding: 0.65%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

22 May 2026 17:18 IST NSE

SMS Pharmaceuticals Board Meeting Outcome

SMS Pharmaceuticals re-appointed Annapragada & Co. as cost auditors and Adusumilli & Associates as internal auditors. Both appointments are for a twelve-month term.

Execution: 12 months

Read the filing ↗